Moving the needle on vaccine preventable diseases.

MMGH uses a unique combination of rigorous academic research, tailor-made teams, specialist knowledge, industry-specific experience, state-of-the-art tools and independent thinking, to provide trusted advice and implementable solutions for programmes and products related to Vaccine Preventable Diseases, and Neglected Tropical Diseases, within the public health sphere.

Filters

  • Focus Areas
    Projects - Focus Areas
    • Evaluation
    • Implementation
    • Policy & Strategy
    • Access
  • Vaccine Preventable Diseases
    Projects - Vaccine Preventable Diseases
    • Cholera
    • COVID-19
    • Diphtheria
    • Enteric Fever
    • Human Papillomavirus
    • Influenza
    • Japanese Encephalitis
    • Leishmaniasis
    • Measles-Rubella
    • Meningitis
Search
Sort By (Projects)
2022 — Ongoing

Supporting the creation of a learning and performance management vision...

In partnership with Jhpiego, MMGH is supporting Gavi, the Vaccine Alliance to establish a set of global quality standards and requirements for the learning and performance management (LPM) approaches and…
Client
Gavi, The Vaccine Alliance
2021 — Ongoing

Papua New Guinea Measles & Rubella campaign...

MMGH is supporting Papua New Guinea in applying for Gavi funds needed to plan and implement a Measles & Rubella (MR) follow-up campaign. The campaign will also include a routine…
Client
Gavi, The Vaccine Alliance
2021 — Ongoing

Piloting approaches for the national cholera plan and GTFCC execution...

In partnership with Global Health Visions, providing support to the Global Task Force on Cholera Control (GTFCC) and the Country Support Platform to develop an approved methodology to support the…
Client
Bill and Melinda Gates Foundation
2021 — Ongoing

Support to GTFCC to develop training materials related to the...

MMGH is supporting the GTFCC and its partners in developing the training materials for a 5-day training session. The training targets country stakeholders that are engaged in the preparation, implementation,…
Client
Centers for Disease Control and Prevention (CDC)
2020 — 2022

COVID-19 Support to World Health Organisation...

MMGH is supporting the Country Readiness and Delivery (CRD) workstream of the COVAX Facility, under the vaccines pillar of the ACT Accelerator, through technical support to the WHO & UNICEF…
Client
World Health Organisation (WHO)
Image Credit: CDC
2019 — 2019

Identification of alternative strategies for the Meningitis International Coordinating Group...

MMGH supported the International Coordinating Group (ICG) for meningitis to improve access to vaccines for the international stockpile. The project sought to understand the reasons for supply constraints of vaccine…
Client
World Health Organisation (WHO)
2019 — 2019

Implementing the Ending Cholera: A Global Roadmap to 2030 Strategy...

MMGH assisted the Global Task Force on Cholera Control (GTFCC), on a Bill & Melinda Gates Foundation grant, in establishing an Oral Cholera Vaccine (OCV) demand forecast platform, a programme…
Client
Global Task Force on Cholera Control
2019 — 2019

Improving access to affordable vaccine supply in Member States of...

MMGH supported the Vaccine-Preventable Diseases and Immunisation Unit of WHO Europe in operationalising the South-Eastern Europe Health Network (SEEHN) vision and principles which focus on securing access to sufficient and…
Client
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2019 — 2019

Application for Gavi support for human papillomavirus vaccine introduction in...

MMGH assisted the National Immunisation Program (NIP), Ministry of Health Cambodia, and the WHO Country Office in Phnom Penh with the Gavi application process for the introduction of the human…
Client
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2018 — 2018

Development of a comprehensive Multi-Year Plan in Lao PDR...

MMGH supported the Ministry of Health and the WHO Country Office of Lao PDR in the review of the National Immunisation Program (NIP) and the establishment and update of a…
Client
World Health Organisation (WHO)
Image Credit: MMGH/Stefano Malvolti
2018 — 2018

Definition of a capacity building plan for Gavi’s Country Programmes...

MMGH supported the Country Programmes department of the Gavi Secretariat in defining its competency model and related training programmes. Partnering with Gavi’s Human Resource and Knowledge Management department and conducting…
Client
Gavi, The Vaccine Alliance
Image Credit: MMGH/Thomas Cherian
2018 — 2018

Definition of a support framework for the establishment of Programme...

MMGH assisted the Gavi Secretariat and Ministry of Health of Myanmar in the development of a roadmap for the establishment of a Programme Performance Monitoring Unit (PPMU), including its staffing,…
Client
Gavi, The Vaccine Alliance
2018 — 2018

Training the trainer for pandemic influenza preparedness...

MMGH supported the WHO Department of Infectious Hazard Management (IHM) in the preparation and facilitation of a workshop on country preparedness for vaccine deployment in the event of an influenza…
Client
World Health Organisation (WHO)
2017 — 2018

Influenza vaccine post-introduction evaluation (IPIE) in middle-income countries...

A tablet-based Influenza Vaccine Post-Introduction Evaluation (IPIE) tool was developed by MMGH jointly with WHO, the U.S. Centers for Disease Control and Prevention (CDC) and the Swiss Tropical and Public…
Client
World Health Organisation (WHO)
Image Credit: MMGH/Thomas Cherian
Image Credit: Lorenzo Pezzoli
2017 — 2017

Definition of the governance setup, funding framework and costing for...

MMGH supported the Global Task Force for Cholera Control in the definition of the new Cholera Control strategy. MMGH focused on the design of the governance and funding framework, as…
Client
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2017 — 2017

Application for Gavi support for Human Papillomavirus and Rotavirus vaccine...

MMGH supported the Ministry of Health and the WHO Country Office of Lao PDR in developing two successful Gavi applications for the introduction of Human Papillomavirus and Rotavirus vaccines.
Client
World Health Organisation (WHO)